Host cytokine responses distinguish invasive from airway isolates of the Streptococcus milleri/anginosis group

BMC Infectious Diseases

Dawn ME Bowdish²  Michael G Surette¹  Chris P Verschoor²  Julienne C Kaiser¹ 

[1]Department of Medicine, Farncombe Family Digestive Health Research Institute, McMaster University, 1280 Main St W, Hamilton, ON L8S 4 K1, Canada

[2]Department of Pathology & Molecular Medicine, McMaster Immunology Research Centre, McMaster University, 1280 Main St W, Hamilton, ON L8S 4 K1, Canada

关键词: Peripheral blood mononuclear cells;    Host response;    Cytokines;    Commensal;    Streptococcus milleri group;   

Others  :  1125569
DOI  :  10.1186/1471-2334-14-498

 received in 2013-11-15, accepted in 2014-09-03,  发布年份 2014

【 摘 要 】

Background

The Streptococcus Milleri/Anginosus Group (SMG) colonize mucosal surfaces, especially the airways, and are considered to be normal mucosal microbiota; however, they are a major cause of abscesses, pneumonia and pleural empyema. The production of exoenzymes and virulence factors do not correlate with SMG pathogenicity. Since SMG infections are associated with robust inflammatory responses, we hypothesized that host immune responses might distinguish strains associated with asymptomatic carriage and those associated with fulminant disease.

Methods

We measured IL1β, TNF, IL10, IL12, IL23, IL17, and IL4 production from human peripheral blood mononuclear cells (PBMCs) stimulated with a panel of clinical isolates from the airways and infections and measured the ability of these isolates to stimulate TLR2.

Results

Isolates were categorized based on the levels of cytokines they induced from PBMCs (high, intermediate, low). Airway isolates predominantly induced low levels of cytokines and isolates from invasive disease induced higher levels, although about 10% of the strains produced divergent cytokine responses between donors. Interestingly, the donors were most divergent in their production of IL17, IL12 and IL23.

Conclusions

We propose that the ability to inhibit or avoid an inflammatory response is associated with carriage in the airways and variability in responses between isolates and donors might contribute to susceptibility to disease.

【 授权许可】

   
2014 Kaiser et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

【 参考文献 】

• [1]Poole PM, Wilson G: Occurrence and cultural features of streptococcus milleri in various body sites. J Clin Pathol 1979, 32(8):764-768.
• [2]Gossling J: Occurrence and pathogenicity of the Streptococcus milleri group. Rev Infect Dis 1988, 10(2):257-285.
• [3]Deutschmann MW, Livingstone D, Cho JJ, Vanderkooi OG, Brookes JT: The significance of Streptococcus anginosus group in intracranial complications of pediatric rhinosinusitis. JAMA Otolaryngol Head Neck Surg 2013, 139(2):157-160.
• [4]Prasad KN, Mishra AM, Gupta D, Husain N, Husain M, Gupta RK: Analysis of microbial etiology and mortality in patients with brain abscess. J Infect 2006, 53(4):221-227.
• [5]Pang TCY, Fung T, Samra J, Hugh TJ, Smith RC: Pyogenic liver abscess: an audit of 10 years’ experience. World J Gastroenterol 2011, 17(12):1622-1630.
• [6]Alvarez Perez JA, Gonzalez JJ, Baldonedo RF, Sanz L, Carreno G, Junco A, Rodriguez JI, Martinez MD, Jorge JI: Clinical course, treatment, and multivariate analysis of risk factors for pyogenic liver abscess. Am J Surg 2001, 181(2):177-186.
• [7]Kaplan GG, Gregson DB, Laupland KB: Population-based study of the epidemiology of and the risk factors for pyogenic liver abscess. Clin Gastroenterol Hepatol 2004, 2(11):1032-1038.
• [8]Lee YQ, Kanagalingam J: Bacteriology of deep neck abscesses: a retrospective review of 96 consecutive cases. Singapore Med J 2011, 52(5):351-355.
• [9]Ahmed RA, Marrie TJ, Huang JQ: Thoracic empyema in patients with community-acquired pneumonia. Am J Med 2006, 119(10):877-883.
• [10]Maskell NA, Davies CW, Nunn AJ, Hedley EL, Gleeson FV, Miller R, Gabe R, Rees GL, Peto TE, Woodhead MA, Lane DJ, Darbyshire JH, Davies RJ: U.K. Controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med 2005, 352(9):865-874.
• [11]Bert F, Bariou-Lancelin M, Lambert-Zechovsky N: Clinical significance of bacteremia involving the “Streptococcus milleri” group: 51 cases and review. Clin Infect Dis 1998, 27(2):385-387.
• [12]Sibley CD, Parkins MD, Rabin HR, Duan K, Norgaard JC, Surette MG: A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients. Proc Natl Acad Sci U S A 2008, 105(39):15070-15075.
• [13]Grinwis ME, Sibley CD, Parkins MD, Eshaghurshan CS, Rabin HR, Surette MG: Characterization of Streptococcus milleri group isolates from expectorated sputum of adult patients with cystic fibrosis. J Clin Microbiol 2010, 48(2):395-401.
• [14]Jacobs JA, Stobberingh EE: Hydrolytic enzymes of Streptococcus anginosus, Streptococcus constellatus and Streptococcus intermedius in relation to infection. Eur J Clin Microbiol Infect Dis 1995, 14(9):818-820.
• [15]Damjanovic D, Divangahi M, Kugathasan K, Small CL, Zganiacz A, Brown EG, Hogaboam CM, Gauldie J, Xing Z: Negative regulation of lung inflammation and immunopathology by TNF-alpha during acute influenza infection. Am J Pathol 2011, 179(6):2963-2976.
• [16]Gwyer Findlay E, Hussell T: Macrophage-mediated inflammation and disease: a focus on the lung. Mediators Inflamm 2012, 2012:140937.
• [17]Giuliano S, Rubini G, Conte A, Goldoni P, Falcone M, Vena A, Venditti M, Morelli S: Streptococcus anginosus group disseminated infection: case report and review of literature. Infez Med 2012, 20(3):145-154.
• [18]Sibley CD, Grinwis ME, Field TR, Eshaghurshan CS, Faria MM, Dowd SE, Parkins MD, Rabin HR, Surette MG: Culture enriched molecular profiling of the cystic fibrosis airway microbiome. PLoS One 2011, 6(7):e22702.
• [19]Sibley CD, Sibley KA, Leong TA, Grinwis ME, Parkins MD, Rabin HR, Surette MG: The Streptococcus milleri population of a cystic fibrosis clinic reveals patient specificity and intraspecies diversity. J Clin Microbiol 2010, 48(7):2592-2594.
• [20]Larsen JM, Steen-Jensen DB, Laursen JM, Sondergaard JN, Musavian HS, Butt TM, Brix S: Divergent pro-inflammatory profile of human dendritic cells in response to commensal and pathogenic bacteria associated with the airway microbiota. PLoS One 2012, 7(2):e31976.
• [21]Frodermann V, Chau TA, Sayedyahossein S, Toth JM, Heinrichs DE, Madrenas JN: A modulatory interleukin-10 response to staphylococcal peptidoglycan prevents Th1/Th17 adaptive immunity to staphylococcus aureus. J Infect Dis 2011, 204(2):253-262.
• [22]Peres AG, Madrenas J: The broad landscape of immune interactions with Staphylococcus aureus: from commensalism to lethal infections. Burns 2013, 39(3):380-388.
• [23]Chau TA, McCully ML, Brintnell W, An G, Kasper KJ, Vines ED, Kubes P, Haeryfar SM, McCormick JK, Cairns E, Heinrichs DE, Madrenas J: Toll-like receptor 2 ligands on the staphylococcal cell wall downregulate superantigen-induced T cell activation and prevent toxic shock syndrome. Nat Med 2009, 15(6):641-648.
• [24]Clarridge JE 3rd, Osting C, Jalali M, Osborne J, Waddington M: Genotypic and phenotypic characterization of “Streptococcus milleri” group isolates from a veterans administration hospital population. J Clin Microbiol 1999, 37(11):3681-3687.
• [25]Grinwis ME, Sibley CD, Parkins MD, Eshaghurshan CS, Rabin HR, Surette MG: Macrolide and clindamycin resistance in Streptococcus milleri group isolates from the airways of cystic fibrosis patients. Antimicrob Agents Chemother 2010, 54(7):2823-2829.
• [26]Whiley RA, Fraser H, Hardie JM, Beighton D: Phenotypic differentiation of Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus strains within the “Streptococcus milleri group”. J Clin Microbiol 1990, 28(7):1497-1501.
• [27]Round JL, Lee SM, Li J, Tran G, Jabri B, Chatila TA, Mazmanian SK: The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science 2011, 332(6032):974-977.
• [28]Jeon SG, Kayama H, Ueda Y, Takahashi T, Asahara T, Tsuji H, Tsuji NM, Kiyono H, Ma JS, Kusu T, Okumura R, Hara H, Yoshida H, Yamamoto M, Nomoto K, Takeda K: Probiotic bifidobacterium breve induces IL-10-producing Tr1 cells in the colon. PLoS Pathog 2012, 8(5):e1002714.
• [29]Smits HH, Engering A, van der Kleij D, de Jong EC, Schipper K, van Capel TM, Zaat BA, Yazdanbakhsh M, Wierenga EA, van Kooyk Y, Kapsenberg ML: Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J Allergy Clin Immunol 2005, 115(6):1260-1267.
• [30]Cua DJ, Tato CM: Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol 2010, 10(7):479-489.
• [31]Havarstein LS, Hakenbeck R, Gaustad P: Natural competence in the genus Streptococcus: evidence that streptococci can change pherotype by interspecies recombinational exchanges. J Bacteriol 1997, 179(21):6589-6594.
• [32]Olson AB, Kent H, Sibley CD, Grinwis ME, Mabon P, Ouellette C, Tyson S, Graham M, Tyler SD, Van Domselaar G, Surette MG, Corbett CR: Phylogenetic relationship and virulence inference of Streptococcus Anginosus Group: curated annotation and whole-genome comparative analysis support distinct species designation. BMC Genomics 2013, 14:895. BioMed Central Full Text
• [33]Cho JS, Guo Y, Ramos RI, Hebroni F, Plaisier SB, Xuan C, Granick JL, Matsushima H, Takashima A, Iwakura Y, Cheung AL, Cheng G, Lee DJ, Simon SI, Miller LS: Neutrophil-derived IL-1beta is sufficient for abscess formation in immunity against Staphylococcus aureus in mice. PLoS Pathog 2012, 8(11):e1003047.
• [34]Vossen MG, Gattringer KB, Khalifeh N, Koreny M, Spertini V, Mallouhi A, Willeit M, Volc-Platzer B, Asboth F, Graninger W, Thalhammer F, Lagler H: Gemella morbillorum bacteremia after anti-tumor necrosis factor alpha as acne inversa therapy. J Clin Microbiol 2012, 50(3):1109-1112.
• [35]Wilson NJ, Boniface K, Chan JR, McKenzie BS, Blumenschein WM, Mattson JD, Basham B, Smith K, Chen T, Morel F, Lecron JC, Kastelein RA, Cua DJ, McClanahan TK, Bowman EP, de Waal Malefyt R: Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 2007, 8(9):950-957.
• [36]Manel N, Unutmaz D, Littman DR: The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat Immunol 2008, 9(6):641-649.
• [37]Hoeve MA, Savage ND, de Boer T, Langenberg DM, de Waal MR, Ottenhoff TH, Verreck FA: Divergent effects of IL-12 and IL-23 on the production of IL-17 by human T cells. Eur J Immunol 2006, 36(3):661-670.
• [38]Zhang Z, Clarke TB, Weiser JN: Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice. J Clin Invest 2009, 119(7):1899-1909.
• [39]Lu YJ, Gross J, Bogaert D, Finn A, Bagrade L, Zhang Q, Kolls JK, Srivastava A, Lundgren A, Forte S, Thompson CM, Harney KF, Anderson PW, Lipsitch M, Malley R: Interleukin-17A mediates acquired immunity to pneumococcal colonization. PLoS Pathog 2008, 4(9):e1000159.
• [40]Aujla SJ, Chan YR, Zheng M, Fei M, Askew DJ, Pociask DA, Reinhart TA, McAllister F, Edeal J, Gaus K, Husain S, Kreindler JL, Dubin PJ, Pilewski JM, Myerburg MM, Mason CA, Iwakura Y, Kolls JK: IL-22 mediates mucosal host defense against gram-negative bacterial pneumonia. Nat Med 2008, 14(3):275-281.
• [41]Ye P, Rodriguez FH, Kanaly S, Stocking KL, Schurr J, Schwarzenberger P, Oliver P, Huang W, Zhang P, Zhang J, Shellito JE, Bagby GJ, Nelson S, Charrier K, Peschon JJ, Kolls JK: Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exper Med 2001, 194(4):519-527.
• [42]Conti HR, Shen F, Nayyar N, Stocum E, Sun JN, Lindemann MJ, Ho AW, Hai JH, Yu JJ, Jung JW, Filler SG, Masso-Welch P, Edgerton M, Gaffen SL: Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med 2009, 206(2):299-311.
• [43]Pandiyan P, Conti HR, Zheng L, Peterson AC, Mathern DR, Hernandez-Santos N, Edgerton M, Gaffen SL, Lenardo MJ: CD4(+)CD25(+)Foxp3(+) regulatory T cells promote Th17 cells in vitro and enhance host resistance in mouse Candida albicans Th17 cell infection model. Immunity 2011, 34(3):422-434.
• [44]Hernandez-Santos N, Huppler AR, Peterson AC, Khader SA, McKenna KC, Gaffen SL: Th17 cells confer long-term adaptive immunity to oral mucosal Candida albicans infections. Mucosal Immunol 2013, 6(5):900-910.
• [45]Miyamoto M, Prause O, Sjostrand M, Laan M, Lotvall J, Linden A: Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways. J Immunol 2003, 170(9):4665-4672.
• [46]Laan M, Cui ZH, Hoshino H, Lotvall J, Sjostrand M, Gruenert DC, Skoogh BE, Linden A: Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol 1999, 162(4):2347-2352.
• [47]Rose WE, Eickhoff JC, Shukla SK, Pantrangi M, Rooijakkers S, Cosgrove SE, Nizet V, Sakoulas G: Elevated serum interleukin-10 at time of hospital admission is predictive of mortality in patients with Staphylococcus aureus bacteremia. J Infect Dis 2012, 206(10):1604-1611.
• [48]Wertheim HF, Vos MC, Ott A, van Belkum A, Voss A, Kluytmans JA, van Keulen PH, Vandenbroucke-Grauls CM, Meester MH, Verbrugh HA: Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet 2004, 364(9435):703-705.
• [49]Holt PG, Strickland DH, Wikstrom ME, Jahnsen FL: Regulation of immunological homeostasis in the respiratory tract. Nat Rev Immunol 2008, 8(2):142-152.